| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000017940 |
| Receipt No. | R000020762 |
| Official scientific title of the study | Comparison of the influences of Sevoflurane or Desflurane on the postoperative state of pediatric general anesthesia |
| Date of disclosure of the study information | 2015/07/01 |
| Last modified on | 2016/06/17 (Ver. 10) |
| Basic information | ||
| Official scientific title of the study | Comparison of the influences of Sevoflurane or Desflurane on the postoperative state of pediatric general anesthesia | |
| Title of the study (Brief title) | The influences of Sevoflurane and Desflurane on the postoperative state of pediatric general anesthesia | |
| Region |
|
|
| Condition | |||||
| Condition | pediatic surgery(inguinal hernia, umbilical hernia)
otolaryngological surgery(tonsillar hypertrophy, adenoidal hypertrophy, otitis media) |
||||
| Classification by specialty |
|
||||
| Classification by malignancy | Others | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | To compare Desflurane with Sevoflurane for the postoperative quality and possible side effects of pediatric general anesthesia |
| Basic objectives2 | Bio-equivalence |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Assessment of the quality during emergence period(agitation, nausea, vomiting) |
| Key secondary outcomes | Assessment of the quality at the point of one hour after returning the ward (agitation, nausea, vomiting) |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | We randomly assign twenty children who undergo pediatric or otolaryngological surgery with 1-6% Sevoflurane at the induction and maintenance of anesthesia. | |
| Interventions/Control_2 | We randomly assign twenty children who undergo pediatric or otolaryngological surgery with 1-6% Sevoflurane at the induction and switched to 3-6% Desflurane at the maintenance of anesthesia. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | children 1-6 years old who receives an elective pediatric or otolaryngological surgery | |||
| Key exclusion criteria | ASA-PS(ASA physical status)>3 or 4, asthma, body weight>25kg | |||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Tomoaki Urabe |
| Organization | Hiroshima Prefectural Hospital |
| Division name | Anesthesiology |
| Address | 1-5-54 Ujinakanda, Minamiku, Hiroshima-city, Hiroshima-prefecture, Japan 734-8530 |
| TEL | 082-3260-5203 |
| tomoakiurabe@gmail.com | |
| Public contact | |
| Name of contact person | Tomoaki Urabe |
| Organization | Hiroshima Prefectural Hospital |
| Division name | Anesthesiology |
| Address | 1-5-54 Ujinakanda, Minamiku, Hiroshima-city, Hiroshima-prefecture, Japan 734-8530 |
| TEL | 082-254-1818 |
| Homepage URL | |
| t-yoshimura87638@pref.hiroshima.lg.jp | |
| Sponsor | |
| Institute | Hiroshima Prefectural Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 県立広島病院 手術室(広島県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020762 |